Khiron Life Sciences Corp. (TSXV:KHRN) announces a share repurchase program. Under the normal course issuer bid, the company will repurchase up to 8,955,893 shares, representing 5% of its issued share capital. All the shares purchased under the bid will be cancelled. The bid is subject to approval of TSX Venture Exchange. The bid will expire on the earlier of one year from such commencement or the date on which the Company has purchased the maximum number of shares to be acquired under the bid. As of September 9, 2021, the company had 179,117,068 outstanding shares.